Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi et al. · New England Journal of Medicine · 2019 · 6.9K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

CDC GROWTH CHARTS FOR THE UNITED STATES: METHODS AND DEVELOPMENT 2000

Robert J. Kuczmarski, Cynthia L. Ogden, S. S. Guo et al. · 2002 · 6.5K citations

Public Health, Population Health Sciences, Disease Surveillance +15

Dapagliflozin in Patients with Chronic Kidney Disease

Hiddo J.L. Heerspink, Bergur V. Stefánsson, Ricardo Correa‐Rotter et al. · New England Journal of Medicine · 2020 · 5.2K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Small Sample Inference for Fixed Effects from Restricted Maximum Likelihood

Michael G. Kenward, James Roger · Biometrics · 1997 · 4.5K citations

Business, Biostatistics, Econometrics +16

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Melanie J. Davies, David A. D’Alessio, Judith Fradkin et al. · Diabetes Care · 2018 · 3.5K citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +17